Ensem Therapeutics

📍 Waltham, United States🗓 Founded 2021👥 21 employees💰 Last funded Apr 2022
Biotechnology🌐 ensemtx.com
Website LinkedIn
The name ENSEM connotes innovations in integrating groundbreaking technologies to decipher structural ENSEMbles and kinetics for drug design. ENSEM is a pioneering drug discovery and development company that leverages its unique Kinetic Ensemble™ platform to develop innovative small molecule precision medicines for oncology, with potential expansion into genetic disorders and other disease areas. ENSEM integrates computational and AI deep learning methodologies with advanced experimental techniques to identify non-obvious binding pockets and accelerate structure-based drug design, with a focus on high-value and difficult-to-drug targets.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2021
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Japan
1
China
1
Frequently asked questions
Who invested in Ensem Therapeutics?
Ensem Therapeutics has 2 investors on record on gritt.io, including 2 early-stage backers.
When did Ensem Therapeutics last raise funding?
The most recent investment in Ensem Therapeutics recorded on gritt.io was in April 2022.
When was Ensem Therapeutics founded?
Ensem Therapeutics was founded in 2021.
What industry is Ensem Therapeutics in?
Ensem Therapeutics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Ensem Therapeutics based?
Ensem Therapeutics is headquartered in Waltham, United States.